CAR-Exosome Agents
Nov 15, 2024
CAR-T Cells vs. CAR-Exosome Agents: Exploring the Future of Cancer Immunotherapy
Immunotherapy has revolutionized the treatment landscape for cancer, offering hope for patients who have exhausted traditional therapeutic options. In the ever-evolving field of immunotherapy, two emerging approaches—CAR-T cells and CAR-Exosome agents—are garnering attention for their potential to revolutionize the...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
